http://www.yso.fi/onto/yso/p5248 amyloidosis
amyloidosis
Biology of disease : molecular pathogenesis of �-amyloidosis in Alzheimer's disease and other cerebral amyloidosis
Haplotype analysis in gelsolin-related amyloidosis reveals independent origin of identical mutation (G654A) of gelsolin in Finland and Japan
Intraoperative death in cardiac amyloidosis with increased QT dispersion in the electrocardiogram
Serum amyloid A (SAA) : proinflammatory functions and their regulation by serum lipoproteins
Quantification of gelsolin in serum of patients with familial amyloidosis, finnish type (FAF)
Summary.
Clinical studies on amyloidosis in rheumatoid arthritis
Familial amyloidosis of the Finnish type (FAF) - consequences of amyloidosis-associated mutation for gelsolin processing and function
Laboratory analyses for evaluation of platelet disorders and platelet concentrates
Postmortem pathological findings in a japanese patient with familial amyloidosis, finnish type (FAF)
Amyloid diseases at old age : a pathological, epidemiological, and genetic study
Deciphering potential factors affecting β-amyloid pathology in idiopathic normal pressure hydrocephalus
Subtle neuropsychiatric and neurocognitive changes in hereditary gelsolin amyloidosis (AGel amyloidosis)
Apolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimerś, Gelsolin and AA amyloids
Endocannabinoid receptors, dopamine system and brain volumetry in amyloid plaque producing APP/PS1 mice
Early detection of Alzheimer's disease ß-amyloid pathology : applicability of positron emission tomography with the amyloid radioligand 11C-PIB
C-terminal fragments of [alpha]- and [beta]-tubulin form amyloid fibrils in vitro and associate with amyloid deposits of familial cerebral amyloid angiopathy, British type
Rheumatic rarities
Inhibition of Alzheimerś amyloidosis by peptides that prevent β-sheet conformation
PET and MR imaging in Parkinson's disease patients with cognitive impairment : a study of dopaminergic dysfunction, amyloid deposition, cortical hypometabolism and brain atrophy
Causes of death in patients with rheumatoid arthritis over a 40-year period : with special emphasis on autopsy
Natural compounds as therapeutic agents for amyloidogenic diseases
Amyloid-β deposition in the brains of subjects with cerebrovascular disease, diabetes, synucleinopathy and alcohol abuse : a human post mortem study
Oral Health in Hereditary Gelsolin Amyloidosis
Amyloidosis associated with inflammatory rheumatic diseases in Finland : declining incidence and better outcome
Tissue distribution and levels of gelsolin mRNA in normal individuals and patients with gelsolin-related amyloidosis
